Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > 5-BROMO-2-PYRAZOL-1-YL-PYRIMIDINE

5-BROMO-2-PYRAZOL-1-YL-PYRIMIDINE

5-BROMO-2-PYRAZOL-1-YL-PYRIMIDINE structure

5-BROMO-2-PYRAZOL-1-YL-PYRIMIDINE 

structure
  • CAS No:

    883230-94-2

  • Formula:

    C7H5BrN4

  • Chemical Name:

    5-BROMO-2-PYRAZOL-1-YL-PYRIMIDINE

  • Synonyms:

    5-Bromo-2-pyrazol-1-yl-pyrimidine;5-BROMO-2-(1H-PYRAZOL-1-YL)PYRIMIDINE;5-bromo-2-(pyrazol-1-yl)pyrimidine;ACMC-209qsc;SCHEMBL2898655;CTK8B2553;KS-00000JWB;DTXSID90672018;5-bromo-2-pyrazol-1-ylpyrimidine;ANW-38986

  • Categories:

    Pharmaceutical Intermediates  >  Heterocyclic Compound

5-BROMO-2-PYRAZOL-1-YL-PYRIMIDINE Basic Attributes

225.0454

223.97000

DTXSID90672018

2933990090

Characteristics

43.6

1.2

1.79g/cm3

402.2°C at 760 mmHg

197ºC

5-BROMO-2-PYRAZOL-1-YL-PYRIMIDINE Use and Manufacturing

General procedure: The 2-substituted 5-halopyridine or 5-halopyrimidine substrate (0.5 mmol), an N-heterocyclic amine (1.0 mmol), Cu(NO3)2 (0.1 mmol) and Cs2CO3 (1.0 mmol) were added to a 25-mL Schlenk tube, followed by addition of DMF (2 mL). This mixture was stirred at 130 °C or 140 °C (see schemes and tables) under air atmosphere for 24 h. Then, the reaction mixture was added to brine (15 mL) and this mixture was extracted with CH2Cl2 (3 × 15 mL). The combined extracts were concentrated under reduced pressure and the product was isolated by flash chromatography on a silica gel (200–300 mesh) column.General procedure: The 2-substituted 5-halopyridine or 5-halopyrimidine substrate (0.5 mmol), an N-heterocyclic amine (1.0 mmol), Cu(NO3)2 (0.1 mmol) and Cs2CO3 (1.0 mmol) were added to a 25-mL Schlenk tube, followed by addition of DMF (2 mL). This mixture was stirred at 130 °C or 140 °C (see schemes and tables) under air atmosphere for 24 h. Then, the reaction mixture was added to brine (15 mL) and this mixture was extracted with CH2Cl2 (3 × 15 mL). The combined extracts were concentrated under reduced pressure and the product was isolated by flash chromatography on a silica gel (200–300 mesh) column.General procedure: The 2-substituted 5-halopyridine or 5-halopyrimidine substrate (0.5 mmol), an N-heterocyclic amine (1.0 mmol), Cu(NO3)2 (0.1 mmol) and Cs2CO3 (1.0 mmol) were added to a 25-mL Schlenk tube, followed by addition of DMF (2 mL). This mixture was stirred at 130 °C or 140 °C (see schemes and tables) under air atmosphere for 24 h. Then, the reaction mixture was added to brine (15 mL) and this mixture was extracted with CH2Cl2 (3 × 15 mL). The combined extracts were concentrated under reduced pressure and the product was isolated by flash chromatography on a silica gel (200–300 mesh) column.General procedure: The 2-substituted 5-halopyridine or 5-halopyrimidine substrate (0.5 mmol), an N-heterocyclic amine (1.0 mmol), Cu(NO3)2 (0.1 mmol) and Cs2CO3 (1.0 mmol) were added to a 25-mL Schlenk tube, followed by addition of DMF (2 mL). This mixture was stirred at 130 °C or 140 °C (see schemes and tables) under air atmosphere for 24 h. Then, the reaction mixture was added to brine (15 mL) and this mixture was extracted with CH2Cl2 (3 × 15 mL). The combined extracts were concentrated under reduced pressure and the product was isolated by flash chromatography on a silica gel (200–300 mesh) column.1st Step

Computed Properties

Molecular Weight:225.05
XLogP3:1.2
Hydrogen Bond Acceptor Count:3
Rotatable Bond Count:1
Exact Mass:223.96976
Monoisotopic Mass:223.96976
Topological Polar Surface Area:43.6
Heavy Atom Count:12
Complexity:146
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.